Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
about
Signaling pathways as therapeutic targets in biliary tract cancer.Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients.Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer.
P2860
Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Capecitabine plus cisplatin as ...... ospective single-center study.
@en
Capecitabine plus cisplatin as ...... ospective single-center study.
@nl
type
label
Capecitabine plus cisplatin as ...... ospective single-center study.
@en
Capecitabine plus cisplatin as ...... ospective single-center study.
@nl
prefLabel
Capecitabine plus cisplatin as ...... ospective single-center study.
@en
Capecitabine plus cisplatin as ...... ospective single-center study.
@nl
P2093
P2860
P356
P1433
P1476
Capecitabine plus cisplatin as ...... ospective single-center study.
@en
P2093
Chang-Min Kim
Eun Kyung Hong
Hyun Bum Kim
Joong-Won Park
Sang Myung Woo
Sang-Jae Park
Sung-Sik Han
Tae Hyun Kim
Woo Jin Lee
Young Hwan Koh
P2860
P304
P356
10.1159/000339499
P577
2012-07-21T00:00:00Z